vs
Side-by-side financial comparison of R F INDUSTRIES LTD (RFIL) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
R F INDUSTRIES LTD is the larger business by last-quarter revenue ($22.7M vs $18.3M, roughly 1.2× ROCKWELL MEDICAL, INC.). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -3.0%, a 3.8% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $2.0M). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs -10.1%).
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
RFIL vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.7M | $18.3M |
| Net Profit | $173.0K | $-554.0K |
| Gross Margin | 36.8% | 21.1% |
| Operating Margin | 4.0% | -2.2% |
| Net Margin | 0.8% | -3.0% |
| Revenue YoY | 22.9% | -25.6% |
| Net Profit YoY | 172.7% | 26.7% |
| EPS (diluted) | $0.01 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.7M | $18.3M | ||
| Q3 25 | $19.8M | $15.9M | ||
| Q2 25 | $18.9M | $16.1M | ||
| Q1 25 | $19.2M | $18.9M | ||
| Q4 24 | $18.5M | $24.7M | ||
| Q3 24 | $16.8M | $28.3M | ||
| Q2 24 | $16.1M | $25.8M | ||
| Q1 24 | $13.5M | $22.7M |
| Q4 25 | $173.0K | $-554.0K | ||
| Q3 25 | $392.0K | $-1.8M | ||
| Q2 25 | $-245.0K | $-1.5M | ||
| Q1 25 | $-245.0K | $-1.5M | ||
| Q4 24 | $-238.0K | $-756.0K | ||
| Q3 24 | $-705.0K | $1.7M | ||
| Q2 24 | $-4.3M | $343.0K | ||
| Q1 24 | $-1.4M | $-1.7M |
| Q4 25 | 36.8% | 21.1% | ||
| Q3 25 | 34.0% | 14.3% | ||
| Q2 25 | 31.5% | 15.6% | ||
| Q1 25 | 29.8% | 16.1% | ||
| Q4 24 | 31.3% | 14.7% | ||
| Q3 24 | 29.5% | 22.0% | ||
| Q2 24 | 29.9% | 17.6% | ||
| Q1 24 | 24.5% | 13.5% |
| Q4 25 | 4.0% | -2.2% | ||
| Q3 25 | 3.6% | -9.9% | ||
| Q2 25 | 0.6% | -8.4% | ||
| Q1 25 | 0.3% | -7.2% | ||
| Q4 24 | 0.5% | -2.1% | ||
| Q3 24 | -2.5% | 6.8% | ||
| Q2 24 | -2.6% | 2.0% | ||
| Q1 24 | -15.5% | -5.8% |
| Q4 25 | 0.8% | -3.0% | ||
| Q3 25 | 2.0% | -11.0% | ||
| Q2 25 | -1.3% | -9.3% | ||
| Q1 25 | -1.3% | -8.0% | ||
| Q4 24 | -1.3% | -3.1% | ||
| Q3 24 | -4.2% | 5.9% | ||
| Q2 24 | -26.7% | 1.3% | ||
| Q1 24 | -10.1% | -7.6% |
| Q4 25 | $0.01 | $-0.01 | ||
| Q3 25 | $0.04 | $-0.05 | ||
| Q2 25 | $-0.02 | $-0.05 | ||
| Q1 25 | $-0.02 | $-0.04 | ||
| Q4 24 | $-0.02 | $-0.02 | ||
| Q3 24 | $-0.07 | $0.04 | ||
| Q2 24 | $-0.41 | $0.01 | ||
| Q1 24 | $-0.13 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.2M | $37.0M |
| Total Assets | $73.0M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $10.7M | ||
| Q3 25 | $3.0M | $13.6M | ||
| Q2 25 | $3.6M | $12.5M | ||
| Q1 25 | $1.3M | $11.4M | ||
| Q4 24 | $839.0K | $15.7M | ||
| Q3 24 | $1.8M | $12.3M | ||
| Q2 24 | $1.4M | $11.9M | ||
| Q1 24 | $4.5M | $6.6M |
| Q4 25 | $35.2M | $37.0M | ||
| Q3 25 | $34.8M | $37.0M | ||
| Q2 25 | $34.2M | $30.4M | ||
| Q1 25 | $34.2M | $31.5M | ||
| Q4 24 | $34.1M | $32.6M | ||
| Q3 24 | $34.1M | $29.1M | ||
| Q2 24 | $34.6M | $23.5M | ||
| Q1 24 | $38.7M | $20.6M |
| Q4 25 | $73.0M | $57.1M | ||
| Q3 25 | $73.2M | $57.5M | ||
| Q2 25 | $72.7M | $52.6M | ||
| Q1 25 | $70.4M | $54.0M | ||
| Q4 24 | $71.0M | $59.2M | ||
| Q3 24 | $71.9M | $57.1M | ||
| Q2 24 | $72.8M | $53.0M | ||
| Q1 24 | $79.1M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.1M | $2.3M |
| Free Cash FlowOCF − Capex | $2.0M | $2.2M |
| FCF MarginFCF / Revenue | 9.0% | 12.0% |
| Capex IntensityCapex / Revenue | 0.3% | 0.5% |
| Cash ConversionOCF / Net Profit | 12.13× | — |
| TTM Free Cash FlowTrailing 4 quarters | $4.3M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.1M | $2.3M | ||
| Q3 25 | $-311.0K | $-1.3M | ||
| Q2 25 | $2.2M | $1.8M | ||
| Q1 25 | $601.0K | $-3.5M | ||
| Q4 24 | $-244.0K | $865.0K | ||
| Q3 24 | $2.4M | $4.3M | ||
| Q2 24 | $197.0K | $1.4M | ||
| Q1 24 | $840.0K | $-2.4M |
| Q4 25 | $2.0M | $2.2M | ||
| Q3 25 | $-419.0K | $-1.5M | ||
| Q2 25 | $2.2M | $1.7M | ||
| Q1 25 | $574.0K | $-3.5M | ||
| Q4 24 | $-418.0K | $470.0K | ||
| Q3 24 | $2.1M | $4.1M | ||
| Q2 24 | $28.0K | $1.2M | ||
| Q1 24 | $697.0K | $-2.5M |
| Q4 25 | 9.0% | 12.0% | ||
| Q3 25 | -2.1% | -9.6% | ||
| Q2 25 | 11.4% | 10.5% | ||
| Q1 25 | 3.0% | -18.8% | ||
| Q4 24 | -2.3% | 1.9% | ||
| Q3 24 | 12.6% | 14.4% | ||
| Q2 24 | 0.2% | 4.5% | ||
| Q1 24 | 5.2% | -11.1% |
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.5% | 1.4% | ||
| Q2 25 | 0.2% | 1.0% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 0.9% | 1.6% | ||
| Q3 24 | 1.5% | 0.7% | ||
| Q2 24 | 1.0% | 1.1% | ||
| Q1 24 | 1.1% | 0.6% |
| Q4 25 | 12.13× | — | ||
| Q3 25 | -0.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
